Rituximab in refractory chronic inflammatory demyelinating polyradiculoneuropathy: report of four cases

J Neurol. 2017 May;264(5):1011-1014. doi: 10.1007/s00415-017-8462-7. Epub 2017 Mar 23.
No abstract available

Publication types

  • Case Reports
  • Letter

MeSH terms

  • Adolescent
  • Adult
  • Aged
  • Humans
  • Immunologic Factors / therapeutic use*
  • Male
  • Polyradiculoneuropathy, Chronic Inflammatory Demyelinating / drug therapy*
  • Rituximab / therapeutic use*
  • Treatment Outcome

Substances

  • Immunologic Factors
  • Rituximab